Chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): Quality of Life (QoL) results from the GO2 phase III trial
Peter S Hall, D. Swinson, S. Lord, C. Handforth, D. Cairns, H. Marshall, R. Petty, M. Bennett, G. Velikova, M.T. Seymour
Research output: Contribution to journal › Meeting abstract › peer-review
Dive into the research topics of 'Chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): Quality of Life (QoL) results from the GO2 phase III trial'. Together they form a unique fingerprint.